Conexeu Sciences

Medical device developer Conexeu Sciences set to direct list on the Nasdaq on May 21 IPO Overview Conexeu Sciences, a preclinical developer of a regenerative tissue device for wound care and aesthetics, filed a resale prospectus with the SEC stating... Read more